Login / Signup

Radiosensitization Effects by Bismuth Oxide Nanoparticles in Combination with Cisplatin for High Dose Rate Brachytherapy.

Noor Nabilah Talik SisinKhairunisak Abdul RazakSafri Zainal AbidinNor Fazila Che MatReduan AbdullahRaizulnasuha Ab RashidMuhammad Afiq Khairil AnuarNur Hamizah Mohd ZainudinNashrulhaq TagilingNorazlina Mat NawiWan Nordiana Rahman
Published in: International journal of nanomedicine (2019)
A BiONPs-Cis combination was unveiled as a novel approach that offers promising radiosensitization enhancement that will increase the efficiency of tumor control while preserving the normal tissue at a reduced dose. This data is the first precedent to prove the synergetic implication of BiONPs, Cis, and HDR brachytherapy that will be beneficial for future chemoradiotherapy strategies in cancer care.
Keyphrases
  • high dose
  • oxide nanoparticles
  • stem cell transplantation
  • low dose
  • locally advanced
  • rectal cancer
  • radiation therapy
  • electronic health record
  • current status
  • big data
  • squamous cell carcinoma
  • machine learning